The latest Tweets from Hartaj Singh (@hartajsingh). “ Or the exquisite delicate thin curve of the new moon in spring; ” W. Whitman, Miracles. New York. Hartaj Singh works at Oppenheimer. Before joining Oppenheimer, he was the director/biotechnology analyst for BTIG and a portfolio manager for Tecumseh. Hartaj Singh is Managing Director and Senior Analyst covering Biotechnology. Prior to joining Oppenheimer, Hartaj was Managing Director and Senior.

Author: Tojataur Brami
Country: Belarus
Language: English (Spanish)
Genre: Career
Published (Last): 21 August 2004
Pages: 161
PDF File Size: 2.44 Mb
ePub File Size: 19.28 Mb
ISBN: 545-7-62248-861-8
Downloads: 59215
Price: Free* [*Free Regsitration Required]
Uploader: Meztit

He holds Finance and Communications degrees from Syracuse University. He joined the firm in and covers four diverse services sub-sectors: Due to permission requirements, not all quotes are shown. His research is focused on finding disruptive macro and micro software trends.

Oppenheimer Analyst Bios

Molecular Therapy 9 5, Ittai holds an M. Prior to Oppenheimer, Brian worked at A.

She originally joined Oppenheimer inn covering Biotechnology. Dominick graduated from Roger Williams University with a B.

He also holds the CFA designation. He also holds an M. Brian graduated from Creighton University with a B.


Prior to Oppenheimer, Tim worked on the buy-side in an investment capacity at BlackRock. A and is a CFA charterholder.

He initially focused on the emerging Israeli technology companies before broadening his coverage to Emerging Technology and Service companies. Prior to Hartwj Street, Jay spent 18 years in the pharmaceutical industry, working mostly for Pfizer in finance, marketing and business development.

Expert – Hartaj Singh

A from the University from Southern California and an M. Hartaj Singh works at Oppenheimer. InJohn was named Head of Equity Research, a position he continues to hold today.

Metal Matrix omposites material. Hartaj began his sell-side career at Lehman Brothers and subsequently moved to the buyside covering Biotechnology at Visium Asset Management and Tecumseh Partners. Growth in company valuations has outpaced sales for several years, but the coming weeks will see rapid fluctuations as the two begin to realign.

New articles by this author. IUP journal of operations management 8 251 He joined the firm inand has been covering the sector since siingh Prior to joining the firm, Chris attended Columbia Business School and started his Wall Street career on the buy-side as an analyst.


Hartaj Singh | The University of Manchester –

Andrew holds a B. Prevalence of substance abuse in schizophrenia: Mark Breidenbach Emerging Biotechnology. John holds hsrtaj B. Dominick has been with the firm sinceoriginally working with Ben Chittenden covering Specialty Finance and Regional Banks. Allison Rudary is a Director and Senior Analyst covering asset managers and business development companies. Please see Overview for more details.

Erica Moffett is Managing Director and Associate Director of Research and works with John Parks in overseeing the firm’s overall research strategy hxrtaj product. Andrew Uerkwitz Emerging Services and Technology.

He holds a B. Leah holds a B. Migration, remittances and rural development: